Symposium - Beijing, China
As one of the most investigated areas in biomedical research, the cancer field is rapidly advancing by translating biological insights towards better detection and therapeutics, including molecular classifications as well as immunotherapies. In the era of the genetically informed, emerging concepts in cancer biology and oncology research are colliding into precision medicine. In order to accelerate the development of personalized cancer therapies and further translate fundamental discoveries into the clinic, there must be open lines of communication at the interface between the lab and the clinic.
Symposium themes:
•Understanding cancer hallmarks – new frontiers
•Cancer hallmarks as therapeutic targets
•Tumor immunology and immunotherapy
•Clinical progress and obstacles
•Managing cancer in the “omics” era
•Understanding cancer hallmarks – new frontiers
•Cancer hallmarks as therapeutic targets
•Tumor immunology and immunotherapy
•Clinical progress and obstacles
•Managing cancer in the “omics” era
- Organization: Cell Press
Sun, Nov 09, 2014 - Tue, Nov 11, 2014
Beijing, China
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
